Keywords: Mylan, Patent challenge, Generess FE, Warner Chilcott, Caduet, Pfizer, Hypertension, Contraceptive, USA

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA

Article | 02 December 2011

Print This

US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by Warner Chilcott ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in